Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,884 | 23,423 | 10,172 | 19,958 | 18,799 |
| Depreciation Amortization | 3,677 | 2,507 | 1,262 | 4,964 | 3,547 |
| Income taxes - deferred | 7,236 | 1,340 | 933 | 2,006 | 185 |
| Accounts receivable | -858 | -30,544 | -49,281 | -6,038 | 4,747 |
| Accounts payable and accrued liabilities | 4,372 | -1,149 | -189 | -457 | -1,165 |
| Other Working Capital | 8,035 | -16,486 | -40,135 | -21,374 | -4,826 |
| Other Operating Activity | 8,452 | 41,371 | 51,792 | 8,258 | -2,031 |
| Operating Cash Flow | $53,798 | $20,462 | $-25,446 | $7,317 | $19,256 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,376 | -9,094 | -4,755 | -20,813 | -16,464 |
| Other Investing Activity | 0 | 0 | 0 | -10,000 | -10,000 |
| Investing Cash Flow | $-14,376 | $-9,094 | $-4,755 | $-30,813 | $-26,464 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30,000 | 30,000 | 15,000 | 60,000 | 45,000 |
| Debt Repayment | -47,596 | -31,625 | -15,659 | -60,751 | -44,544 |
| Common Stock Issued | 4,193 | 1,134 | 651 | 3,391 | 620 |
| Other Financing Activity | 1,555 | 513 | 196 | 6,328 | 5,000 |
| Financing Cash Flow | $-11,848 | $22 | $188 | $8,968 | $6,076 |
| Exchange Rate Effect | -270 | -355 | -80 | 271 | 90 |
| Beginning Cash Position | 91,473 | 91,473 | 91,473 | 105,730 | 105,730 |
| End Cash Position | 118,777 | 102,508 | 61,380 | 91,473 | 104,688 |
| Net Cash Flow | $27,304 | $11,035 | $-30,093 | $-14,257 | $-1,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | 53,798 | 20,462 | -25,446 | 7,317 | 19,256 |
| Capital Expenditure | -14,376 | -9,094 | -4,755 | -20,813 | -16,464 |
| Free Cash Flow | 39,422 | 11,368 | -30,201 | -13,496 | 2,792 |